National Health Investors INC (NHI) — SEC Filings

Overview

National Health Investors INC (NHI) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a DEFA14A filed on Apr 3, 2026: National Health Investors Inc. (NHI) filed a Definitive Additional Materials (DEFA14A) on April 3, 2026. This filing is related to proxy materials and does not contain specific financial figures or proposals for shareholder vote in this document.

Sentiment Summary

Across 30 filings, the sentiment breakdown is: 1 bullish, 29 neutral. The dominant filing sentiment for National Health Investors INC is neutral.

Filing Type Overview

National Health Investors INC (NHI) has filed 1 ARS, 5 DEFA14A, 12 8-K, 5 10-Q, 2 10-K, 1 8-K/A, 1 DEF 14A, 1 10-K/A, 2 SC 13G/A with the SEC between Jan 2024 to Apr 2026.

Filings by Year

2026 · 2025 · 2024

Recent Filings (30)

• ARS Filing — ARS · Apr 3, 2026
• NHI Files Definitive Additional Proxy Materials — DEFA14A · Apr 3, 2026 Risk: low
  National Health Investors Inc. (NHI) filed a Definitive Additional Materials (DEFA14A) on April 3, 2026. This filing is related to proxy materials and does not
• NHI Elects New Directors, Updates Executive Compensation — 8-K · Dec 19, 2025 Risk: low
  National Health Investors Inc. announced on December 15, 2025, changes in its board of directors and executive compensation. Specifically, the company elected t
• NHI's Q3 Revenue Jumps 8% Amid Aggressive Real Estate Acquisitions — 10-Q · Nov 6, 2025 Risk: medium
  NATIONAL HEALTH INVESTORS INC (NHI) reported a robust financial performance for the nine months ended September 30, 2025, with total revenues increasing by 8.17
• National Health Investors Enters Material Agreement — 8-K · Sep 26, 2025 Risk: medium
  On September 22, 2025, National Health Investors Inc. entered into a material definitive agreement, creating a direct financial obligation. The company, incorpo
• NHI Files 8-K for Other Events — 8-K · Sep 8, 2025 Risk: medium
  National Health Investors, Inc. (NHI) filed an 8-K on September 8, 2025, to report "Other Events." The filing does not contain specific details about the nature
• NHI Q2 Net Income Dips to $34.5M Amid Stable Revenue — 10-Q · Aug 6, 2025 Risk: low
  NATIONAL HEALTH INVESTORS INC (NHI) reported a net income of $34.5 million for the three months ended June 30, 2025, a decrease from $36.2 million in the prior-
• NHI Files 8-K for Regulation FD Disclosure — 8-K · Jun 2, 2025 Risk: low
  National Health Investors Inc. (NHI) filed an 8-K on June 2, 2025, to report a Regulation FD disclosure. The filing does not contain specific details about the
• NHI Reports on Shareholder Votes and Corporate Details — 8-K · May 28, 2025 Risk: low
  National Health Investors Inc. (NHI) filed an 8-K on May 28, 2025, reporting on matters submitted to a vote of security holders as of May 21, 2025. The filing d
• NHI Urges Vote FOR Proposals, Responds to ISS — DEFA14A · May 13, 2025 Risk: medium
  National Health Investors Inc. (NHI) has issued a definitive additional materials filing on May 13, 2025, responding to a recommendation from Institutional Shar
• National Health Investors Files 8-K — 8-K · May 5, 2025 Risk: low
  National Health Investors Inc. filed an 8-K on May 5, 2025, reporting information under Regulation FD and including financial statements and exhibits. The filin
• NHI Files Proxy Materials — DEFA14A · Apr 30, 2025 Risk: low
  National Health Investors Inc. (NHI) filed a Definitive Additional Materials proxy statement on April 30, 2025. This filing relates to materials provided to sha
• NHI Mails Shareholder Letter on Returns — DEFA14A · Apr 17, 2025 Risk: low
  National Health Investors Inc. (NHI) filed a DEFA14A on April 17, 2025, announcing they mailed a letter to stockholders. This letter highlights the company's su
• NHI Files Proxy Materials for Shareholder Meeting — DEFA14A · Apr 8, 2025 Risk: low
  National Health Investors Inc. (NHI) filed a Definitive Additional Materials proxy statement on April 8, 2025. The filing concerns materials related to their an
• National Health Investors Inc. Files 8-K: Director Changes & Officer Compensation — 8-K · Mar 27, 2025 Risk: low
  On March 27, 2025, National Health Investors Inc. filed an 8-K report. The filing primarily concerns the departure of a director, the election of a new director
• NHI Files 2024 10-K: Real Estate REIT Reports Annual Performance — 10-K · Feb 25, 2025 Risk: medium
  National Health Investors Inc. (NHI) filed its 2024 10-K on February 25, 2025, reporting on its fiscal year ending December 31, 2024. The company, a real estate
• NHI Elects New Director, Robert A. DeLong — 8-K · Feb 10, 2025 Risk: low
  National Health Investors Inc. announced on February 10, 2025, that its Board of Directors has elected Robert A. DeLong as a new director, effective February 7,
• NHI Amends Director and Officer Filings — 8-K/A · Jan 8, 2025 Risk: low
  National Health Investors Inc. filed an 8-K/A on January 8, 2025, to amend a previous filing. The amendment pertains to the departure of a director, election of
• NHI Appoints New CFO, Details Compensation — 8-K · Dec 2, 2024 Risk: low
  National Health Investors Inc. announced on December 2, 2024, the appointment of Robert J. Stephenson as Chief Financial Officer, effective December 16, 2024. S
• NHI Files Q3 2024 10-Q Report — 10-Q · Nov 5, 2024 Risk: low
  National Health Investors Inc. (NHI) filed its 10-Q for the period ending September 30, 2024. The company, a real estate investment trust, reported its financia
• National Health Investors Enters Material Agreement, Incurs Financial Obligation — 8-K · Oct 25, 2024 Risk: medium
  On October 24, 2024, National Health Investors, Inc. entered into a material definitive agreement and created a direct financial obligation. The company, headqu
• National Health Investors Enters Material Definitive Agreement — 8-K · Aug 16, 2024 Risk: medium
  On August 14, 2024, National Health Investors Inc. entered into a material definitive agreement. The company also filed financial statements and exhibits as par
• NHI Files Q2 2024 10-Q: Financials and Operations Update — 10-Q · Aug 6, 2024 Risk: medium
  National Health Investors Inc. (NHI) filed its 10-Q for the period ending June 30, 2024. The company reported its financial performance for the second quarter a
• NHI Files 8-K on Shareholder Vote Matters — 8-K · May 29, 2024 Risk: low
  National Health Investors Inc. (NHI) filed an 8-K on May 29, 2024, reporting on matters submitted to a vote of security holders. The earliest reported date for
• National Health Investors Inc. Files 10-Q for Q1 2024 — 10-Q · May 6, 2024 Risk: low
  NATIONAL HEALTH INVESTORS INC (NHI) filed a Quarterly Report (10-Q) with the SEC on May 6, 2024. National Health Investors Inc. filed its 10-Q report for the pe
• National Health Investors Inc. Files Definitive Proxy Statement — DEF 14A · Apr 4, 2024 Risk: low
  NATIONAL HEALTH INVESTORS INC (NHI) filed a Proxy Statement (DEF 14A) with the SEC on April 4, 2024. National Health Investors Inc. filed a Definitive Proxy Sta
• National Health Investors Inc. Files 10-K/A Amendment — 10-K/A · Feb 26, 2024 Risk: low
  NATIONAL HEALTH INVESTORS INC (NHI) filed a Amended Annual Report (10-K/A) with the SEC on February 26, 2024. National Health Investors Inc. filed an amendment
• National Health Investors Inc. Files 2023 Annual Report on Form 10-K — 10-K · Feb 20, 2024 Risk: medium
  NATIONAL HEALTH INVESTORS INC (NHI) filed a Annual Report (10-K) with the SEC on February 20, 2024. National Health Investors Inc. (NHI) filed its 2023 Form 10-
• Vanguard Holds 16.9% Stake in National Health Investors Inc. — SC 13G/A · Feb 13, 2024 Risk: low
  The Vanguard Group, a major investment firm, filed an amended SC 13G/A on February 13, 2024, disclosing its ownership in National Health Investors Inc. As of De
• BlackRock Updates Passive Stake in National Health Investors — SC 13G/A · Jan 8, 2024
  BlackRock Inc. filed an amended SC 13G/A on January 8, 2024, indicating its ownership of Common Stock in NATIONAL HEALTH INVESTORS INC as of December 31, 2023.

Risk Profile

Risk Assessment: Of NHI's 28 recent filings, 0 were flagged as high-risk, 9 as medium-risk, and 19 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.

Financial Highlights

Key financial metrics from National Health Investors INC's most recent 10-Q filing (Nov 6, 2025):

• Revenue: $269.81M
• Net Income: $103.86M
• EPS: $2.22
• Debt-to-Equity: 0.74
• Cash Position: $81.63M
• Operating Margin: N/A
• Total Assets: $2.69B
• Total Debt: $1.11B

Key Executives

• Robert J. Neely
• David J. Scholl
• John J. Williams
• John E. Green
• Roger L. Wilson
• Dana Hambly
• Robert A. DeLong
• Robert J. Stephenson

Industry Context

National Health Investors Inc. operates within the healthcare real estate investment trust (REIT) sector, focusing on senior housing and medical office buildings. The industry is characterized by an aging demographic driving demand, but also by increasing operating costs, regulatory complexities, and a competitive landscape for acquisitions. Trends include a shift towards more specialized care facilities and the impact of reimbursement policies.

Top Tags

REIT (8) · corporate-governance (5) · sec-filing (3) · amendment (3) · 10-Q (3) · proxy-filing (2) · Healthcare Real Estate (2) · Financial Performance (2) · Dividend Stock (2) · material-agreement (2)

Key Numbers

• Total Revenues: $269.81M — Increased 8.17% for the nine months ended September 30, 2025, from $249.43 million in 2024.
• Net Income Attributable to Common Stockholders: $103.86M — Increased 9.73% for the nine months ended September 30, 2025, from $94.65 million in 2024.
• Diluted Earnings Per Share: $2.22 — Increased from $2.17 for the nine months ended September 30, 2024, to $2.22 in 2025.
• Acquisitions of Real Estate Properties: $130.98M — Significantly increased from $9.87 million in 2024, indicating aggressive expansion.
• Cash and Cash Equivalents: $81.63M — Increased from $24.29 million at December 31, 2024, demonstrating strong liquidity.
• Debt, Net: $1.11B — Decreased from $1.15 billion at December 31, 2024, improving the balance sheet.
• Total Assets: $2.69B — Increased from $2.61 billion at December 31, 2024, reflecting portfolio growth.
• Net Cash Provided by Operating Activities: $168.83M — Increased from $150.20 million in 2024, indicating strong operational performance.
• Proceeds from Senior Notes: $346.16M — New financing secured during the nine months ended September 30, 2025.
• Proceeds from Common Shares, Net: $134.92M — Equity raised during the nine months ended September 30, 2025.
• SEC File Number: 001-10822 — Identifier for the company's filings
• IRS Employer Identification No.: 62-1470956 — Tax identification number
• Q2 2025 Net Income: $34.5M — Decreased from $36.2M in Q2 2024
• Q2 2025 Revenue: $75.8M — Slightly down from $76.5M in Q2 2024
• YTD 2025 Net Income: $68.7M — Decreased from $71.9M in YTD 2024

Forward-Looking Statements

• {"claim":"Vanguard will likely maintain a significant, passive stake in National Health Investors Inc. for the foreseeable future.","entity":"The Vanguard Group","targetDate":"2025-12-31","confidence":"high"}

Related Companies

WELL · HCN · VTR

Frequently Asked Questions